GUTSFRACTYL HEALTH, INC.同业对比
FRACTYL HEALTH, INC. 与SIC 3841 行业的逐项对比:市值、估值、增长、盈利能力、质量与总回报,以及在同业组内的排名。所有数值均由引擎从 SEC 申报与延迟行情计算,排名仅为组内排序位置 —— 描述性数据,非投资建议。
完整同业对比
同业组:同 SIC 行业分类 | 公司 | 市值 | 市盈率(TTM) | 市净率 | 市销率 | 营收同比增长 | 净利同比增长 | 息税前利润率 | 净资产收益率 | 投入资本回报率 | 皮氏 F 值 | 一年总回报 | 股息率 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| GUTS本股 | $110M#7 | — | 5.1x#5 | — | -100.0%#9 | -105.2%#9 | — | -659.4%#8 | — | — | -63.0%#6 | — |
| INFU | $184M#1 | 24.6x#1 | 3.1x#3 | 1.3x#3 | 6.4%#6 | 182.6%#1 | 8.3%#1 | 11.3%#1 | 9.7%#1 | 8#1 | — | — |
| FEMY | $177M#3 | — | 24.3x#8 | 77.3x#7 | 40.8%#3 | 1.0%#6 | -767.0%#6 | -255.5%#5 | — | — | -82.3%#7 | — |
| LUCD | $177M#2 | — | 44.4x#9 | 37.7x#6 | 8.3%#5 | -27.4%#8 | -1054.8%#7 | -1450.3%#9 | — | 3#4 | -10.3%#1 | — |
| STIM | $137M#4 | — | 10.3x#6 | 0.9x#2 | 99.2%#2 | 10.8%#5 | -21.1%#3 | -294.0%#6 | -43.2%#3 | 2#6 | -55.1%#5 | — |
| CVRX | $136M#5 | — | 4.7x#4 | 2.4x#4 | 10.4%#4 | 11.1%#4 | -90.5%#4 | -183.1%#4 | -275.2%#5 | 3#4 | -35.8%#3 | — |
| MBOT | $115M#6 | — | 1.5x#1 | 982.6x#8 | -88.5%#8 | -14.8%#7 | -12613.0%#8 | -17.7%#3 | -20.9%#2 | 5#3 | -32.3%#2 | — |
| SKIN | $90M#8 | — | 1.6x#2 | 0.3x#1 | -10.0%#7 | 67.4%#2 | -6.9%#2 | -17.2%#2 | — | — | -54.9%#4 | — |
| XAIR | $79M#9 | — | 12.9x#7 | 10.3x#5 | 107.3%#1 | 28.7%#3 | -378.2%#5 | -542.8%#7 | -258.1%#4 | 6#2 | -91.2%#8 | — |
数值来自 SEC 申报与延迟行情;排名仅为该组内的排序位置 —— 描述性数据,不构成评级或建议。 本表构建超时,仅覆盖该组的一部分成员;排名仅相对于已列出的行,稍后会自动补全。 数据构建于 2026-08-03。
数据来自 SEC XBRL 申报与延迟行情 · 排名为组内排序 · 仅供参考 · 非投资建议